Two Sigma Advisers
ASLN

Two Sigma Advisers’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Two Sigma Advisers’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-475
Closed -$34K – 2844
2021
Q3 		$34K Sell
475
-363
-43% -$41.3K ﹤0.01% 2392
2021
Q2 		$111K Buy
838
+485
+137% +$60.6K ﹤0.01% 2333
2021
Q1 		$47K Buy
+353
New +$44.7K ﹤0.01% 2500

Other funds holding ASLN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Two Sigma Advisers's ASLN Position: Q4 2021 in Review

Two Sigma Advisers sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2021, closing a stake of 475 shares — an estimated $34K sold.

Two Sigma Advisers first reported a position in ASLN in Q1 2021 and held it in 3 quarters. The position peaked at $111K in Q2 2021. 33 funds tracked by Wall St. Rank hold ASLN as of Q4 2021.

  • Two Sigma Advisers reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 475 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2021, an estimated $34K.
  • Two Sigma Advisers first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Two Sigma Advisers's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $111K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.